Amphastar Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH) on August 10, 2021, covering the event date of August 5, 2021. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the announced retirement of Richard Koo from the Board of Directors. His departure is effective as of September 30, 2021. The Company explicitly states that this retirement is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Outlook and Management Commentary
Management expressed appreciation for Mr. Koo's eighteen years of service and contributions to the Company. No financial guidance, risk factors, contingencies, or unusual items were disclosed in this specific filing.
Key Investor Verification Points
- Confirm the effective date of Richard Koo's retirement (September 30, 2021).
- Verify if a successor director has been nominated or appointed to fill the vacancy.
- Review subsequent filings for any impact on Board committee assignments or corporate governance policies.